I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| fibroblast | 4 studies | 40% ± 15% | |
| smooth muscle cell | 4 studies | 40% ± 22% | |
| pericyte | 3 studies | 40% ± 20% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| fibroblast | 4 studies | 40% ± 15% | |
| smooth muscle cell | 4 studies | 40% ± 22% | |
| pericyte | 3 studies | 40% ± 20% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 3 studies | 48% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ovary | 100% | 853.63 | 180 / 180 | 100% | 14.23 | 430 / 430 |
| esophagus | 100% | 247.02 | 1442 / 1445 | 100% | 11.51 | 183 / 183 |
| prostate | 100% | 291.36 | 245 / 245 | 99% | 5.37 | 498 / 502 |
| intestine | 100% | 272.71 | 966 / 966 | 98% | 9.13 | 519 / 527 |
| uterus | 100% | 438.22 | 170 / 170 | 98% | 7.46 | 451 / 459 |
| stomach | 100% | 221.33 | 358 / 359 | 98% | 10.64 | 281 / 286 |
| bladder | 100% | 308.29 | 21 / 21 | 98% | 6.41 | 493 / 504 |
| breast | 100% | 303.91 | 459 / 459 | 97% | 5.38 | 1090 / 1118 |
| thymus | 100% | 265.74 | 652 / 653 | 97% | 5.91 | 588 / 605 |
| lung | 100% | 239.23 | 576 / 578 | 97% | 6.04 | 1119 / 1155 |
| brain | 100% | 170.39 | 2632 / 2642 | 97% | 7.83 | 682 / 705 |
| pancreas | 99% | 214.57 | 324 / 328 | 95% | 3.92 | 169 / 178 |
| skin | 100% | 302.01 | 1809 / 1809 | 93% | 5.09 | 441 / 472 |
| adrenal gland | 100% | 266.76 | 258 / 258 | 92% | 4.25 | 212 / 230 |
| kidney | 100% | 235.85 | 89 / 89 | 88% | 3.90 | 791 / 901 |
| liver | 93% | 95.58 | 210 / 226 | 50% | 1.87 | 205 / 406 |
| adipose | 100% | 282.73 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 10.31 | 29 / 29 |
| spleen | 100% | 264.33 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 5.59 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 6.21 | 1 / 1 |
| blood vessel | 100% | 235.48 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| heart | 98% | 155.74 | 843 / 861 | 0% | 0 | 0 / 0 |
| muscle | 97% | 146.75 | 782 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 96% | 5.17 | 77 / 80 |
| peripheral blood | 85% | 210.20 | 794 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0000398 | Biological process | mRNA splicing, via spliceosome |
| GO_0071013 | Cellular component | catalytic step 2 spliceosome |
| GO_0003730 | Molecular function | mRNA 3'-UTR binding |
| Gene name | HNRNPA1L3 |
| Protein name | Heterogeneous nuclear ribonucleoprotein A1-like 3 (Heterogeneous nuclear ribonucleoprotein A1 pseudogene 48) |
| Synonyms | HNRNPA1P48 |
| Description | |
| Accessions | ENST00000565308.3 A0A2R8Y4L2 ENST00000698152.1 |
